BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

  October 29, 2025

   · 

  3 min read
• Press Releases

  Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution

  October 29, 2025

   · 

  13 min read
• Press Releases

  Context Therapeutics to Participate in Upcoming November 2025 Investor Conferences

  October 29, 2025

   · 

  2 min read
• Press Releases

  European Commission Approves KEYTRUDA® (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)

  October 29, 2025

   · 

  19 min read
• Press Releases

  Bausch + Lomb Announces Third-Quarter 2025 Results

  October 29, 2025

   · 

  19 min read
• Press Releases

  United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results

  October 29, 2025

   · 

  11 min read
• Press Releases

  Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

  October 29, 2025

   · 

  9 min read
• Press Releases

  BioNTech to Host Innovation Series R&D Day on November 11, 2025

  October 29, 2025

   · 

  1 min read
• Press Releases

  Sonoma Biotherapeutics Announces Positive Interim Safety and Efficacy Data from Phase 1 REGULATE-RA Study of SBT-77-7101 in Refractory Rheumatoid Arthritis

  October 29, 2025

   · 

  5 min read
• Press Releases

  CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

  October 29, 2025

   · 

  32 min read